Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

BACKGROUND: This report assesses the efficacy and safety of palbociclib plus endocrine therapy (ET) in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC) with or without visceral metastases. PATIENTS AND METHODS: Pre- and postmenopaus...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, N C, Finn, R S, Martin, M, Im, S -A, DeMichele, A, Ettl, J, Diéras, V, Moulder, S, Lipatov, O, Colleoni, M, Cristofanilli, M, Lu, D R, Mori, A, Giorgetti, C, Iyer, S, Bartlett, C Huang, Gelmon, K A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888946/
https://www.ncbi.nlm.nih.gov/pubmed/29342248
http://dx.doi.org/10.1093/annonc/mdx797

Ejemplares similares

Ejemplares similares